Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Net-Receivables" stands at 611.76 Billion Japanese Yens as of 06/30/2025.
As of the end of Daiichi Sankyo Co. Ltd.'s first quarter, the item "Net Receivables" stands at 611.76 Billion JPY. This represents an increase of 24.83 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.36 percent compared to the value the year prior.
The 1 year change in percent is 12.36.
The 3 year change in percent is 110.20.
The 5 year change in percent is 150.84.
The 10 year change in percent is 148.30.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Receivables | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Receivables | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Receivables | 280,205,508,085.11 |